Literature DB >> 11518687

Sustained esophageal contraction: a motor correlate of heartburn symptom.

N Pehlivanov1, J Liu, R K Mittal.   

Abstract

Heartburn occurs in the presence as well as the absence of acid reflux. We searched for a motor correlate of heartburn. Twelve subjects with heartburn were studied with 24-h synchronized pressure, pH, and high-frequency intraluminal ultrasound (HFIUS) imaging of the esophagus. The HFIUS images were analyzed every 2 s for a period of 2 min before and 30 s after the onset of heartburn during 20 acid reflux-positive and 20 acid reflux-negative heartburn episodes. The esophageal muscle thickness was measured as a marker of contraction. Esophageal pressure and HFIUS images were recorded during the Bernstein test in 15 subjects. Sustained esophageal contractions (SECs) were identified during 13 of 20 heartburn episodes associated with acid reflux and 15 of 20 heartburn episodes without acid reflux. SECs were detected during 2 of 40 matched control periods only (P < 0.05). The duration of SECs was 44.9 +/- 26.9 s. The Bernstein test reproduced heartburn symptoms in 8 of 15 subjects. SECs were identified during 6 of 8 (75%) Bernstein-positive and in 1 of 7 (14.3%) Bernstein-negative tests (P = 0.04). We conclude that a SEC precedes both spontaneous and induced heartburn symptoms and may be the cause of heartburn sensation.

Entities:  

Mesh:

Year:  2001        PMID: 11518687     DOI: 10.1152/ajpgi.2001.281.3.G743

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  41 in total

Review 1.  Functional heartburn: the stimulus, the pain, and the brain.

Authors:  R Fass; G Tougas
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 2.  Oesophageal motor functions and its disorders.

Authors:  R K Mittal; V Bhalla
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

3.  Ambulatory high-resolution manometry, lower esophageal sphincter lift and transient lower esophageal sphincter relaxation.

Authors:  R K Mittal; A Karstens; E Leslie; A Babaei; V Bhargava
Journal:  Neurogastroenterol Motil       Date:  2011-11-10       Impact factor: 3.598

4.  A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.

Authors:  Kyoichi Adachi; Kenji Furuta; Hiroto Miwa; Tadayuki Oshima; Masaharu Miki; Yoshinori Komazawa; Katsuhiko Iwakiri; Takahisa Furuta; Tomoyuki Koike; Tomohiko Shimatani; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

Review 5.  Treatment of esophageal (noncardiac) chest pain: an expert review.

Authors:  Enrique Coss-Adame; Askin Erdogan; Satish S C Rao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-28       Impact factor: 11.382

6.  Intraluminal acid induces oesophageal shortening via capsaicin-sensitive neurokinin neurons.

Authors:  William G Paterson; David V Miller; Neil Dilworth; Joseph B Assini; Sandra Lourenssen; Michael G Blennerhassett
Journal:  Gut       Date:  2007-05-24       Impact factor: 23.059

Review 7.  The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus.

Authors:  J H Peters
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

Review 8.  Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Authors:  Nicola de Bortoli; Irene Martinucci; Massimo Bellini; Edoardo Savarino; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 9.  Current perspectives on the diagnosis and treatment of functional esophageal disorders.

Authors:  Roy Dekel; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 10.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.